Related Experiment Video

Updated: Aug 11, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Potent antitumor agent proteasome inhibitors: a novel trigger for Bcl2 phosphorylation to induce apoptosis

S A You1, A Basu, S Haldar

  • 1Rammelkamp Center for Education and Research, Department of Pharmacology, Ireland Cancer Center, MetroHealth/Case Western Reserve University, Cleveland, OH 44109-1998, USA.

International Journal of Oncology
|September 24, 1999
PubMed

Insights

Proteasome inhibitors like MG132 induce cancer cell death by triggering programmed cell death and cell cycle arrest. This study reveals MG132-induced tumor cell killing is mediated through Bcl2 phosphorylation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Proteasome inhibitors exhibit sustained cytotoxicity against human cancer cells.
  • The mechanism involves programmed cell death and cell cycle arrest at the G2-M phase, similar to microtubule-disrupting agents.
  • Antineoplastic drugs can induce tumor cell death via phosphorylation of antiapoptotic proteins like Bcl2, Bcl-xL, and MCL-1.

Purpose of the Study:

  • To investigate the mechanism of tumor cell killing by the proteasome inhibitor MG132.
  • To determine the role of Bcl2 phosphorylation in MG132-induced apoptosis.

Main Methods:

  • Treatment of human cancer cells with the proteasome inhibitor MG132.
  • Analysis of cell death pathways, including apoptosis and cell cycle progression.
  • Assessment of antiapoptotic protein phosphorylation, specifically Bcl2.

Main Results:

  • MG132 induced programmed cell death and G2-M cell cycle arrest in cancer cells.
  • Simultaneous apoptosis and Bcl2 phosphorylation were observed in MG132-treated cells.
  • Evidence suggests a direct link between MG132 treatment and Bcl2 phosphorylation.

Conclusions:

  • The proteasome inhibitor MG132 effectively kills tumor cells through a mechanism involving programmed cell death.
  • Bcl2 phosphorylation is a key mediator of MG132-induced tumor cell killing.
  • These findings highlight the role of proteasome inhibition in cancer therapy via modulation of apoptotic pathways.

More Related Videos

Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...